Literature DB >> 13903377

Immunological determinants of polyoma virus oncogenesis.

K HABEL.   

Abstract

Adult mice and hamsters can be made resistant to an isologous transplantable polyoma tumor by an inapparent infection with polyoma virus. This resistance is cell-mediated and seems not to be related to anti-viral serum antibodies. The basis of the resistance appears to be a transplantation type of cellular immunity directed against a "foreign" antigen contained in the tumor cell. Evidence has been presented to demonstrate this tumor antigen. It is possible that this phenomenon may explain the lack of oncogenesis by polyoma virus infection of adult mice, and the rarity of naturally occurring polyoma tumors.

Entities:  

Keywords:  NEOPLASMS/virology; VIRUSES/immunology

Mesh:

Substances:

Year:  1962        PMID: 13903377      PMCID: PMC2137469          DOI: 10.1084/jem.115.1.181

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  On the interaction between tumor viruses and cells: a virogenetic concept of tumorigenesis.

Authors:  L A ZILBER
Journal:  J Natl Cancer Inst       Date:  1961-06       Impact factor: 13.506

2.  Transplantation of polyoma virus induced tumor in the hamster.

Authors:  K HABEL; P ATANASIU
Journal:  Proc Soc Exp Biol Med       Date:  1959-10

3.  Resistance of polyoma virus immune animals to transplanted polyoma tumors.

Authors:  K HABEL
Journal:  Proc Soc Exp Biol Med       Date:  1961-04

4.  Relationship of polyoma virus and tumor in vivo.

Authors:  K HABEL; R J SILVERBERG
Journal:  Virology       Date:  1960-11       Impact factor: 3.616

5.  The epidemiology of mouse polyoma virus infection.

Authors:  W P ROWE
Journal:  Bacteriol Rev       Date:  1961-03

6.  Studies of mouse polyoma virus infection. III. Distribution of antibodies in laboratory mouse colonies.

Authors:  W P ROWE; J W HARTLEY; L W LAW; R J HUEBNER
Journal:  J Exp Med       Date:  1959-05-01       Impact factor: 14.307

7.  Studies of mouse polyoma virus infection. 1. Procedures for quantitation and detection of virus.

Authors:  W P ROWE; J W HARTLEY; J D ESTES; R J HUEBNER
Journal:  J Exp Med       Date:  1959-04-01       Impact factor: 14.307

  7 in total
  21 in total

1.  A SPECIFIC COMPLEMENT-FIXING ANTIGEN PRESENT IN SV40 TUMOR AND TRANSFORMED CELLS.

Authors:  P H BLACK; W P ROWE; H C TURNER; R J HUEBNER
Journal:  Proc Natl Acad Sci U S A       Date:  1963-12       Impact factor: 11.205

2.  THE INCORPORATION OF SV40 MATERIAL INTO ADENOVIRUS 7 AS MEASURED BY INTRANUCLEAR SYNTHESIS OF SV40 TUMOR ANTIGEN.

Authors:  F RAPP; J L MELNICK; J S BUTEL; T KITAHARA
Journal:  Proc Natl Acad Sci U S A       Date:  1964-12       Impact factor: 11.205

3.  [Virus etiology of leukemias].

Authors:  A GEORGII
Journal:  Blut       Date:  1962

4.  Evidence of continuous transmission of non-infectious SV 40 viral genome in most or all SV 40 hamster tumor cells.

Authors:  A B SABIN; M A KOCH
Journal:  Proc Natl Acad Sci U S A       Date:  1963-03-15       Impact factor: 11.205

5.  Development of virology as an independent science.

Authors:  G K HIRST
Journal:  Br Med J       Date:  1962-05-26

6.  Strain specific cell-mediated response to polyoma-transformed fibroblasts in mice.

Authors:  J A Molinari; J L Ebersole; D Platt
Journal:  Arch Gesamte Virusforsch       Date:  1973

7.  [Analysis of virus induced transplantation immunity to SV40-tumors: significance of humoral antibodies and SV40-specific surface antigen (author's transl)].

Authors:  N Seemayer; H Weis; G Seemayer
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

8.  Surface membrane antigens of PY-3T3 mouse fibroblasts.

Authors:  J A Molinari; J L Ebersole; D Platt
Journal:  Arch Gesamte Virusforsch       Date:  1974

9.  Immunological relationships of some oncogenic DNA viruses. I. Transplantation immunity studies.

Authors:  C W Potter; J M Hoskins; J S Oxford
Journal:  Arch Gesamte Virusforsch       Date:  1969

10.  Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen.

Authors:  L P Chen; E K Thomas; S L Hu; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.